Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Swollen lymph nodes serve as a crucial early warning system when the body fights HIV. These changes often appear subtle at first but persist beyond the duration of typical viral infections.

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...